Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 5;13(7):1098.
doi: 10.3390/jpm13071098.

Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context

Affiliations
Review

Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context

Machel Leuschner et al. J Pers Med. .

Abstract

Interethnic and interindividual variability in in vivo cytochrome P450 (CYP450)-dependent metabolism and altered drug absorption via expressed transport channels such as P-glycoprotein (P-gp) contribute to the adverse drug reactions, drug-drug interaction and therapeutic failure seen in clinical practice. A cost-effective phenotyping approach could be advantageous in providing real-time information on in vivo phenotypes to assist clinicians with individualized drug therapy, especially in resource-constrained countries such as South Africa. A number of phenotyping cocktails have been developed and the aim of this study was to critically assess the feasibility of their use in a South African context. A literature search on library databases (including AccessMedicine, BMJ, ClinicalKey, MEDLINE (Ovid), PubMed, Scopus and TOXLINE) was limited to in vivo cocktails used in the human population to phenotype phase I metabolism and/or P-gp transport. The study found that the implementation of phenotyping in clinical practice is currently limited by multiple administration routes, the varying availability of probe drugs, therapeutic doses eliciting side effects, the interaction between probe drugs and extensive sampling procedures. Analytical challenges include complicated sample workup or extraction assays and impractical analytical procedures with low detection limits, analyte sensitivity and specificity. It was concluded that a single time point, non-invasive capillary sampling, combined with a low-dose probe drug cocktail, to simultaneously quantify in vivo drug and metabolite concentrations, would enhance the feasibility and cost-effectiveness of routine phenotyping in clinical practice; however, future research is needed to establish whether the quantitative bioanalysis of drugs in a capillary whole-blood matrix correlates with that of the standard plasma/serum matrixes used as a reference in the current clinical environment.

Keywords: African genetic diversity; CYP450; P-gp; personalized medicine; phenotyping cocktail.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

References

    1. Johansson I., Ingelman-Sundberg M. Genetic polymorphism and toxicology—With emphasis on cytochrome p450. Toxicol. Sci. 2010;120:1–13. doi: 10.1093/toxsci/kfq374. - DOI - PubMed
    1. Patel T.K., Patel P.B. Mortality among patients due to adverse drug reactions that lead to hospitalization: A meta-analysis. Eur. J. Clin. Pharmacol. 2018;74:819–832. doi: 10.1007/s00228-018-2441-5. - DOI - PubMed
    1. Murray C.J.L., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4. - DOI - PubMed
    1. Mouton J.P., Njuguna C., Kramer N., Stewart A., Mehta U., Blockman M., Fortuin-De Smidt M., De Waal R., Parrish A.G., Wilson D.P., et al. Adverse drug reactions causing admission to medical wards: A cross-sectional survey at 4 hospitals in South Africa. Medicine. 2016;95:e3437. doi: 10.1097/MD.0000000000003437. - DOI - PMC - PubMed
    1. Samer C.F., Lorenzini K.I., Rollason V., Daali Y., Desmeules J.A. Applications of CYP450 testing in the clinical setting. Mol. Diagn. Ther. 2013;17:165–184. doi: 10.1007/s40291-013-0028-5. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources

-